Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Diary Bunda Aplikasi Kehamilan

Diary Bunda Aplikasi Kehamilan

By Alodokter

Diary Bunda is a pregnancy and parenting tracking application for Indonesian mothers, providing medically-reviewed content and specialist access on Android.

The App DNA

What makes this app unique?

The app removes the cognitive cost of navigating generic, non-localized pregnancy advice by providing a single, medically-verified source for regional health standards.

For Pregnant women and new parents in Indonesia seeking medically-reviewed guidance and community support.

What does it look like?

Key features

Specialist Doctor Q&Aedge

Direct access to partner medical specialists for pregnancy and child health inquiries.

Pregnancy Diarystandard

Digital journal for recording progress and memories with photo attachment support.

Community Forumstandard

Discussion space for mothers to share experiences, ask questions, and participate in polls.

How much does it cost?

freeFree access to all features

The app operates on an ad-supported model with no IAP, prioritizing user acquisition and data-driven engagement.

Velocity

Steady developmentShow more...

See all version history

Who built it?

Alodokter

3 apps tracked · Parenting

Alomedika - AI dan SKP dokterAlomedika - AI dan SKP dokterAlodokter: Chat Bersama DokterAlodokter: Chat Bersama Dokter
Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

Google Play
4.75 · 15k

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for Diary Bunda Aplikasi Kehamilan

How's the Parenting market?

Diary Bunda currently holds the #88 position in the Indonesian Parenting category. The gap between its localized medical authority and the feature-rich global rivals necessitates a pivot toward higher-engagement tools to improve chart rank.

Read the market outlook

The rivals identified

The Bump: Baby & Pregnancy App

By The Knot Inc.

The Bump is a global category leader that directly competes for the attention of expectant mothers through high-fidelity tracking and comprehensive registry tools.

  • Offers advanced 3D interactive growth visualizations that provide a more immersive experience than static imagery
  • Integrates a multi-retailer registry tracker, capturing high-intent shopping traffic that Diary Bunda currently lacks
  • Provides a robust Planner+ appointment system that centralizes medical visits within the core user journey
Diary Bunda Aplikasi Kehamilan vs The Bump: Baby & Pregnancy App

Unlock the head-to-head verdict: where this rival wins, and where it loses.

Access the full report for free

The Analyst's Read

Key takeaways for Diary Bunda Aplikasi Kehamilan

Where is it heading?

The Indonesian parenting market is consolidating around apps that offer both medical authority and high-fidelity engagement tools. Diary Bunda's reliance on static content leaves it exposed to rivals that offer interactive, partner-focused experiences, necessitating a shift toward more immersive features to maintain its user base.

  • The app maintains a stable, ad-supported model, but the lack of feature-led engagement leaves it vulnerable to global rivals entering the Indonesian market.
  • The current #88 category rank suggests that the existing feature set is not enough to maintain a top-tier chart position against fresh entrants.

The SWOT

Core Strengths
  • Localized medical content reviewed by specialists provides a defensible barrier against global rivals.
  • Alodokter Group integration offers a seamless pathway to professional medical consultations.
Critical Frictions 2 weaknesses inside
Growth Levers
  • Implementing a partner mode could foster family engagement, a feature currently absent in the local market.
  • Expanding the content library to include post-birth wellness could extend the product lifecycle.
Market Threats 2 threats identified

Next best moves

1 Invest · 1 Maintain

Ship a dedicated partner mode because current features lack family-centric engagement → increase DAU/MAU ratio

+ 1 more prioritized move

The counter-intuitive read

The app's medical-first positioning is a liability if…

Read the full take

Feature gaps

3D interactive growth visualizations (available in The Bump but absent here) +2

Since the last report: Diary Bunda transitioned from a basic pregnancy tracker to a community-focused health resource by adding specialist Q&A and forum features. This pivot addresses the engagement gap against global competitors in the Indonesian market.

Bottom line

Integrating partner-focused features would address the engagement gap against global rivals, unlocking higher session frequency and retention in the competitive Indonesian parenting market.

Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Sources

  1. [1] Play Store listing, source

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Diary Bunda Aplikasi Kehamilan, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

Diary Bunda transitioned from a basic pregnancy tracker to a community-focused health resource by adding specialist Q&A and forum features. This pivot addresses the engagement gap against global competitors in the Indonesian market.

added

Specialist and Community Features

shifted

Expanded Target Audience

shifted

Medical-First Positioning

Cite this report

Marlvel.ai. “Diary Bunda Aplikasi Kehamilan Intelligence Report.” Updated Jul 30, 2026. https://marlvel.ai/apps/com-diarybunda

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0